# An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP

> **NCT02338414** · PHASE2 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- Immune Thrombocytopenia

## Interventions

- **DRUG:** Romiplostim

## Key facts

- **NCT ID:** NCT02338414
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2015-12
- **Final completion:** 2016-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2015-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02338414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02338414, "An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02338414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*